Wen Fang Liu
Direktor/Vorstandsmitglied bei SINCO PHARMACEUTICALS HOLDINGS LIMITED
Aktive Positionen von Wen Fang Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SINCO PHARMACEUTICALS HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 01.02.2016 | - |
| Independent Dir/Board Member | 01.02.2016 | - |
Karriereverlauf von Wen Fang Liu
Ehemalige bekannte Positionen von Wen Fang Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 27.02.2011 | 09.07.2018 |
| Independent Dir/Board Member | 27.02.2011 | 09.07.2018 | |
| HUALAN BIOLOGICAL ENGINEERING INC. | Direktor/Vorstandsmitglied | 01.01.2000 | 01.01.2007 |
| Chinese Academy of Medical Sciences | Corporate Officer/Principal | 01.01.1988 | 01.01.1998 |
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 04.03.2011 | - |
| Independent Dir/Board Member | 27.02.2011 | - |
Ausbildung von Wen Fang Liu
| Chinese Academy of Sciences | Undergraduate Degree |
| Chinese Academy of Forestry | Undergraduate Degree |
Statistik
International
| China | 6 |
| 2 | |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HUALAN BIOLOGICAL ENGINEERING INC. | Health Technology |
| SINCO PHARMACEUTICALS HOLDINGS LIMITED | Distribution Services |
| Private Unternehmen | 2 |
|---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
China Biologic Products Holdings, Inc.
 China Biologic Products Holdings, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China. | Health Technology |
- Börse
- Insiders
- Wen Fang Liu
- Erfahrung
